Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Millennium submits MAA for Velcade in E.U.

Feb. 7, 2003

Corixa reacquires North American rights to lung cancer vaccines

Feb. 7, 2003

Tricyclic antitumor agents covered by Yung Shin patent

Feb. 7, 2003

Vion awarded SBIR grant for further Tapet studies

Feb. 7, 2003

Novel tyrosine kinase inhibitors in Merck pipeline

Feb. 7, 2003

Novel cytotoxic metabolite isolated from marine bacterium

Feb. 6, 2003

AES-14 granted fast track status for oral mucositis associated with cancer chemotherapy

Feb. 6, 2003

Japanese marketing approval sought for Glivec for GIST indication

Feb. 6, 2003

Schering presents new VEGF inhibitors

Feb. 6, 2003

New data on the anticancer efficacy of the nitrosourea derivative aranoza

Feb. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...